We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 391.00
Bid: 391.00
Ask: 392.00
Change: 3.00 (0.77%)
Spread: 1.00 (0.256%)
Open: 392.50
High: 393.00
Low: 389.50
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Resolutions of the Board of Directors: Dividends

3 Apr 2020 07:00

RNS Number : 6590I
Banco Santander S.A.
02 April 2020
 

 

Banco Santander, S.A. (the "Bank" or "Santander"), in accordance with the provisions of the Spanish capital markets regulations, announces the following:

INSIDE INFORMATION

On 23 March the Bank communicated its decision to cancel the interim dividend for fiscal year 2020 and to postpone any decision on the 2020 dividends until there is more visibility on the full impact of this crisis.

This decision was taken to ensure the Bank has as much flexibility as possible to allow it to maximize lending and support businesses and individuals affected by the coronavirus (COVID-19) pandemic, despite the fact that the Bank meets the capital requirements to maintain its current dividend policy (i.e. a 40-50% payout ratio) and is comfortable with its capital buffers over regulatory requirements.

Last Friday, 27 March 2020, the European Central Bank (ECB) requested through a recommendation issued to all European banks under its supervision to preserve capital by cancelling the payment of dividends against 2019 and 2020 results with precisely the same objectives the Bank outlined with its aforementioned actions.

This recommendation explicitly said that those entities that had already called their general shareholders meeting, as was the case for the Bank, should change their dividend proposal to comply with the recommendation. In addition, on 31 March a Royal Decree-Law 11/2020 was approved in Spain expressly providing for and enabling the withdrawal of the proposed application of 2019 earnings from general shareholders meetings which have already been convened. This new rule thus explicitly allows the Bank to follow the ECB recommendation.

Today, taking into consideration the ECB recommendation and in line with the Bank's mission to help people and businesses prosper, the board of the Bank has decided to cancel the payment of the final dividend against 2019 results and the dividend policy for 2020 approving for that purpose the following resolutions:

1. To revise its dividend policy, including for the application of the 2020 results, in the sense that the board's intention is now not to propose any dividend distribution to shareholders until there is more visibility of the effects of the COVID-19 crisis and the 2020 results are known;

2. To withdraw from the agenda of the ordinary general shareholders meeting of the Bank that will be held tomorrow 3 April 2020 on second call the proposals under points Two (Application of 2019 results) and Seven A (Capital increase against reserves to implement the scrip dividend that was contemplated in connection with the above mentioned application of results). This withdrawal does not affect the Bank's annual accounts (nor, therefore, requires them to be restated) nor the approval of the points under point One (Annual accounts and corporate management) nor under any other points of the agenda, as provided for by Royal Decree-Law 11/2020 and the joint communication issued by the Spanish National Securities Commission and the Spanish Registrars Society on 26 March 2020;

3. To withdraw the resolutions of the board passed on 28 January and 27 February through which the above mentioned proposed application of 2019 results was put forward for approval by the ordinary general shareholders meeting; and 

4. To expressly establish that the board's intention is that the new proposed application of 2019 results, which will be submitted for approval by a new general shareholders meeting to be held within the legal term prescribed for holding the ordinary general shareholders meeting (and which is expected to take place in October 2020), will be to apply the 2019 results in full (excluding the amount of the interim dividend paid in November 2019 which totalled 1,661,811,458.20 euros) to voluntary reserves, without prejudice to the possibility of it being then resolved to propose to such general shareholders meeting a distribution following a reassessment of the situation once the uncertainties caused by the COVID-19 crisis disappear.

 

Boadilla del Monte (Madrid), 2 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUPUQACUPUGMP
Date   Source Headline
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval
27th Sep 20237:00 amRNSDividend approval & buyback program implementation
19th Sep 20237:00 amRNSSantander aligns several models to its strategy
18th Sep 20235:14 pmRNSPerpetual Preferred Securities: rate replacement
31st Aug 20233:09 pmRNSTotal Voting Rights
31st Jul 20232:35 pmRNSTotal Voting Rights
28th Jul 20235:35 pmRNSStress Test Results
28th Jul 202312:56 pmRNSHalf-year Report
26th Jul 20237:00 amRNS1H2023 Results - Press release
26th Jul 20237:00 amRNS1H2023 Results Report & Earnings Presentation
19th Jul 202311:52 amRNSNotice of First Half 2023 Results
30th Jun 20233:28 pmRNSFurther re capital reduction
30th Jun 20232:23 pmRNSTotal Voting Rights
27th Jun 20236:07 pmRNSTotal Voting Rights
27th Jun 20236:03 pmRNSCapital reduction (buy-back programme shares)
31st May 202312:19 pmRNSTotal Voting Rights
19th May 202310:51 amRNSDirector/PDMR Shareholding
18th May 20235:20 pmRNSSantander informs of the MREL determined by SRB
3rd May 202311:38 amRNSCovered Bonds: interest rate replacement
28th Apr 202311:39 amRNSTotal Voting Rights
28th Apr 202311:24 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNS1Q2023 Financial report & Earnings presentation
25th Apr 20237:00 amRNS1Q2023 Results - Press release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.